Skip to Main Content

Yale Pathology Diagnostic Pathology CME Annual Review Scheduled for September 17-18 at Yale Club of NYC

May 02, 2022

The Yale Department of Pathology presents its inaugural Diagnostic Pathology CME Annual Review on September 17-18 at the Yale Club of New York City.

This inaugural course at the Yale Club in the heart of Midtown Manhattan will focus on the recent World Health Organization updates in all major pathology subspecialties. This unique two-day program offers a fully engaged learning experience through didactic lecturing and case presentations provided by world-class Yale faculty. The course emphasizes knowledge gains in morphologic recognition and applications of ancillary studies (molecular, genomic and immunohistochemistry) in the most challenging areas, particularly new disease classification and updated diagnostic criteria.

Featured faculty from Yale School of Medicine and elsewhere include:

Course Director: Pei Hui, MD, PhD, Professor of Pathology; Director, Gynecologic Pathology

Adebowale Adeniran, MD, Professor of Pathology; Director, Cytological Pathology

Natalia Buza, MD, Professor of Pathology; Director, Gynecological Pathology Fellowship

Sanja Dacic, MD, PhD, Professor of Pathology; Director of Anatomic Pathology

Joanna Gibson, MD, PhD, Associate Professor of Pathology; Director of Quality and Patient Safety

Peter Humphrey, MD, PhD, Professor of Pathology; Director, Genitourinary Pathology

Anita Huttner, MD, Associate Professor; Director, Neurologic Pathology

William Laskin, MD, Associate Professor, Director, Soft Tissue and Bone Pathology

Chen Liu, MD, PhD, Anthony N. Brady Professor and Chair of Pathology

Jennifer McNiff, MD, Professor of Dermatology and Pathology; Director, Yale Dermatopathology Laboratory

Raffaella Morotti, MD, Professor of Pathology, Director, Pediatric Pathology

Manju Prasad, MD, Professor of Pathology; Director, Endocrine, Head and Neck Pathology

Marie Robert, MD, Professor of Pathology and of Medicine (Digestive Disease); Director, Gastrointestinal and Liver Pathology

Stuart Schnitt, MD, Chief of Breast Oncologic Pathology, Associate Director, Dana-Farber/Brigham and Women’s Breast Oncology Program, Professor of Pathology, Harvard Medical School

Mina Xu, MD, Associate Professor of Pathology and Laboratory Medicine; Director of Hematopathology

WHO Tumor Classifications have become the gold standard reference book series in serving as a systemic educational tool for practicing pathologists to adopt new disease classifications and related diagnostic criteria. Recent developments in diagnostic pathology, particularly molecular genetic discoveries, have introduced new and reclassified entities as well as refined diagnostic criteria for many exiting disease processes.

These recent developments call for an update for practicing pathologists, which is why this comprehensive review course is essential and highly desirable.

This course is targeted to general and subspecialty pathologists in academic and community practice settings and at all career/expertise level. The highly experienced faculty teaching this course are editorial board members and/or contributing authors to the most recent WHO blue book series.

Upon completion of this course, participants should be able to:

  • Gain competency in applying new disease criteria and disease classifications
  • Gain competency in using ancillary studies to achieve accurate diagnosis
  • Becoming efficient in applying morphologic criteria in correlation with clinical findings for accurate pathology reporting
  • Learn strategies to avoid mismanagement and to enhance communication with clinical teams to ensure optimal patient care

For more information, please contact Dr. Pei Hui at 203-785-6498 or Maria Lee at 203-785-6363.

REGISTRATION NOTES

This course is designed for pathologists at both academic and community practice settings at all career levels. Pathology trainees are also encouraged to attend.

A reduced rate is offered to pathology residents and fellows. A letter from the residency or fellowship program director is needed to document the applicant's status. Please send proof of residency or fellowship for reduced fee waiver code in advance of registration.

Registration fees include attendance, electronic handout materials, and meals (breakfast and coffee on September 17 and 18, and lunch on September 17). Cancellation must be received in writing no later than August 15, 2022. Refunds are subject to a $50 administrative fee.

$450 for on-site or after August 15, 2022

$400 for early bird registration by August 15, 2022

$300 for pathology trainee registration on-site or after August 15, 2022

$250 for pathology trainee early bird registration by August 15, 2022

To register online, please visit Yale Diagnostic Pathology CME Annual Review (touchnet.net).

To mail in payment, please submit registration information and payment to the attention of Maria Lee at:

Yale University, Department of Pathology, PO BOX 208023, New Haven, CT 06520-8023

Travel and associated activities continue to pose a potential risk for exposure to COVID-19. We encourage you to assess risks prior to travel and apply safe practices accordingly. The Yale Department of Pathology, and attendees by extension, will observe Yale University, The Yale Club, CDC, and travel guidelines during the event.

Hotel reservations may be made at The Yale Club of New York City by contacting the hotel directly, or at a nearby hotel of the attendee's choice.

CME Credit

The Yale School of Medicine designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Yale School of Medicine designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement: Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Submitted by Terence P. Corcoran on March 28, 2022